Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 187 participants.
Also called NCT01505790
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 187 participants
- Registry
-
NCT01505790
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT01505790. Randomized; no masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2012-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
- Condition
- Acute Coronary Syndromes
- Intervention (Drug)
- PRASUGREL
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
Record details
- Record id
cardio:ct-nct01505790- Content hash
5db70b76afb9657190baf959a26a5c8a8113c128613ce6ee9364fdd20117e037